LifeStance Health Group, Inc. (LFST)

SCOTTSDALE, Ariz., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the fourth quarter and full year ended December 31, 2025.

SCOTTSDALE, Ariz., Feb. 09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, will issue its fourth quarter and full year 2025 earnings release before the market opens on Wednesday, February 25, 2026.

LifeStance Health Group (NASDAQ: LFST - Get Free Report) and Addus HomeCare (NASDAQ: ADUS - Get Free Report) are both mid-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, valuation, dividends, profitability and analyst recommendations. Profitability This table compares LifeStance Health

LifeStance Health Group, Inc. (NASDAQ: LFST - Get Free Report) Director Robert Bessler sold 119,942 shares of the stock in a transaction on Friday, December 19th. The stock was sold at an average price of $7.04, for a total transaction of $844,391.68. Following the sale, the director directly owned 1,318,983 shares in the company, valued at

LifeStance Health Group, Inc. (NASDAQ: LFST - Get Free Report) Director Robert Bessler sold 6,442 shares of the business's stock in a transaction dated Thursday, December 18th. The shares were sold at an average price of $7.00, for a total transaction of $45,094.00. Following the completion of the sale, the director owned 1,378,954 shares of the

LifeStance Health Group, Inc. (NASDAQ: LFST - Get Free Report) insider Ann Varanakis sold 50,000 shares of LifeStance Health Group stock in a transaction dated Wednesday, December 17th. The shares were sold at an average price of $6.90, for a total value of $345,000.00. Following the sale, the insider directly owned 315,610 shares in the company,

LifeStance Health Group, Inc. (NASDAQ: LFST - Get Free Report) Director Robert Bessler sold 79,630 shares of the firm's stock in a transaction dated Friday, December 12th. The stock was sold at an average price of $7.01, for a total value of $558,206.30. Following the completion of the transaction, the director owned 1,382,175 shares in the

The mean of analysts' price targets for LifeStance Health (LFST) points to a 30.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

AXQ Capital LP bought a new position in shares of LifeStance Health Group, Inc. (NASDAQ: LFST) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 66,262 shares of the company's stock, valued at approximately $343,000. Other hedge

Quest Diagnostics (NYSE: DGX - Get Free Report) and LifeStance Health Group (NASDAQ: LFST - Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, earnings, valuation, institutional ownership, dividends, analyst recommendations and risk. Institutional and Insider Ownership 88.1% of Quest

The average of price targets set by Wall Street analysts indicates a potential upside of 33.4% in LifeStance Health (LFST). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

LifeStance Health Group, Inc. ( LFST ) Q3 2025 Earnings Call November 6, 2025 8:30 AM EST Company Participants Monica Prokocki - Vice President of Investor Relations David Bourdon - CEO & Director Ryan McGroarty - CFO & Treasurer Conference Call Participants Craig Hettenbach - Morgan Stanley, Research Division Lisa Gill - JPMorgan Chase & Co, Research Division Matthew Mardula Brian Tanquilut - Jefferies LLC, Research Division Richard Close - Canaccord Genuity Corp., Research Division Kevin Caliendo - UBS Investment Bank, Research Division David Larsen - BTIG, LLC, Research Division Steven Dechert - KeyBanc Capital Markets Inc., Research Division Presentation Operator Ladies and gentlemen, thank you for standing by. My name is Colby, and I'll be your conference operator today.

LifeStance Health Group (LFST) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.02 per share a year ago.

SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the third quarter ended September 30, 2025.

LifeStance Survey Reveals How the Holidays Affect Mental Health, with Stress and Social Pressure Hitting Millennials and Gen Z Hardest SCOTTSDALE, Ariz. , Nov. 5, 2025 /PRNewswire/ -- Findings from a LifeStance Health survey released today reveal that for many Americans, the holiday season involves a complex mix of emotions, including reported feelings of stress and pressure.

SCOTTSDALE, Ariz., Oct. 28, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced that management will present at the upcoming UBS Global Healthcare Conference, which will be hosted in Palm Beach Gardens, FL.